[FATE] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
15-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -27.53%
YoY- -20.88%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 2,515 2,632 1,026 1,027 1,322 0 0 -
PBT -33,520 -19,760 -14,135 -10,126 -8,377 -7,881 -6,980 29.85%
Tax 0 1,091 331 111 27 1 0 -
NP -33,520 -19,760 -14,135 -10,126 -8,377 -7,881 -6,980 29.85%
Tax Rate - - - - - - - -
Total Cost 36,035 22,392 15,161 11,153 9,699 7,881 6,980 31.43%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -1,332.80 -750.76 -1,377.68 -985.98 -633.66 0.00 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.44 -0.30 -0.27 -0.24 -0.29 -0.38 -0.34 4.38%
EPS Diluted -0.44 -0.30 -0.27 -0.24 -0.29 -0.38 -0.34 4.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.